Janssen Diagnostics Garners CE-IVD Mark for Flu/RSV Panel on Biocartis Platform | GenomeWeb

This article has been corrected from a previous version to indicate that Janssen Diagnostics received CE marking for the Idylla Respiratory IFV-RSV Panel.

NEW YORK (GenomeWeb) – Belgian molecular diagnostics company Biocartis announced today that its partner Janssen Diagnostics has received CE-IVD marking for the Idylla Respiratory IFV-RSV Panel, which runs on Biocartis' fully automated PCR-based Idylla platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.

Sponsored by

This webinar will discuss a partnership model for noninvasive prenatal testing that enabled LifeLabs Genetics, a genetic testing lab based in Toronto, Ontario, to implement NIPT in house.